Novo Nordisk Long-Term Investments 2010-2024 | NVO

Novo Nordisk long-term investments for the quarter ending June 30, 2024 were $0.239B, a 10.79% increase year-over-year.

  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
  • Novo Nordisk long-term investments for 2022 were $0.19B, a 17.05% decline from 2021.
  • Novo Nordisk long-term investments for 2021 were $0.229B, a 9.19% decline from 2020.

Novo Nordisk Long-Term Investments 2010-2024 | NVO

  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
  • Novo Nordisk long-term investments for 2022 were $0.19B, a 17.05% decline from 2021.
  • Novo Nordisk long-term investments for 2021 were $0.229B, a 9.19% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B